Ledger.Open graph →
SEC Form D · filed February 2, 2021

Inspyr Therapeutics, Inc

Offering
—
Sold
—
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
WESTLAKE VILLAGE, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (9)

Michael Cain · Westlake Village, CAExec · DirectorScott Ogilvie · Westlake Village, CADirectorClaire Thom · Westlake Village, CADirectorCaspar A. Berendsen · London, United KingdomDirectorAlexandra Hess · London, United KingdomDirectorSupraj R. Rajagopalan · London, United KingdomExec · DirectorJackson K. Fairbanks · Dallas, TXDirectorMatthew Krueger · Dallas, TXExec · DirectorArman Sarkhani · Dallas, TXDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗